Investigating how tumor cell interactions with macrophages affect resistance to prostate cancer therapy
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
This study is looking at how certain immune cells in the body might make prostate cancer tougher to treat with common therapies, and by understanding this, the researchers hope to find better ways to help patients like you respond to treatment.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10651105 on NIH RePORTER |
What this research studies
This research focuses on understanding how tumor-associated macrophages, a type of immune cell, contribute to the resistance of prostate cancer to androgen receptor-targeted therapies. By analyzing the interactions between these macrophages and cancer cells, the study aims to uncover the metabolic changes that promote cancer growth and therapy resistance. The researchers will use advanced techniques to explore how cholesterol metabolism and other factors influence these interactions, potentially leading to new therapeutic strategies. Patients may benefit from insights that could improve treatment outcomes for prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with prostate cancer who are undergoing androgen receptor-targeted therapy.
Not a fit: Patients with non-prostate cancers or those not receiving androgen receptor-targeted therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for prostate cancer by overcoming resistance to current therapies.
How similar studies have performed: Other research has shown promising results in targeting immune cell interactions in cancer, suggesting that this approach may yield significant insights.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Elkenawi, Asmaa — Indiana University Indianapolis
- Study coordinator: Elkenawi, Asmaa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.